Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine and Melphalan Conditioning for Multiple Myeloma
NCT00916058Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Apr 2009
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM), sponsored by Weill Cornell Medicine. Started Apr 2009; status: completed.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00916058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916058.